Aligning diabetes surveillance with clinical reality The Lancet Diabetes & Endocrinology +++ +...

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00404-8/fulltext?dgcid=raven_jbs_etoc_email Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial Prof Frederick J Raal, MD PhDa frederick.raal@wits.ac.za ∙ Prof Jean Bergeron, MDb ∙ Prof Daniel Gaudet, MD PhDc ∙ Robert S Rosenson, MDd ∙ Prof David R Sullivan, MDe ∙ Traci Turner, MDf ∙ et al. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00290-6/abstract?dgcid=raven_jbs_etoc_feature_landia Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study Elsa Vazquez Arreola, PhDa,† ∙ Prof Qiuhong Gong, MDb,† ∙ Robert L Hanson, MDa ∙ Jinping Wangd ∙ Leontine Sandforth, MDe,f,g ∙ Siyao He, MDb ∙ et al. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00295-5/fulltext?dgcid=raven_jbs_etoc_feature_landia Feb 2026 Volume 14Number 2p93-186, e2 https://www.thelancet.com/journals/landia/issue/vol14no2/PIIS2213-8587(25)X0014-0